Studies and Trials

6+ hour, 9+ min ago   (1628+ words) Treatment goals for Crohn’s disease are shifting from simply controlling symptoms such as abdominal pain and diarrhea to suppressing intestinal inflammation as much as possible and achieving deeper remission, including endoscopic remission, or “mucosal healing.” The stakes are particularly high…...

5+ hour, 17+ min ago   (700+ words) What if a person who needs a pacemaker no longer had to undergo surgery to have one implanted? Imagine having no wires threaded into the heart, no pulse generator implanted under the skin and, potentially, no repeat procedures to deal…...

8+ hour, 42+ min ago   (1475+ words) By David Stephen “neurons and nerves — via a variety of mechanisms that researchers are still teasing apart — seem to regulate almost everything about cancer, from tumor initiation in many cases to tumor growth, tumor invasion and metastasis, probably resistance to…...

5+ hour, 40+ min ago   (291+ words) Loneliness among the elderly is emerging as a serious but often overlooked concern, doctors have warned. Older adults can feel isolated even while living with their families, and prolonged social disconnection can take a toll on both their mental and…...

6+ hour, 8+ min ago   (1024+ words) Clinical Leader Guest Column | September 14, 2026 How AI Will Reshape Study Start-Up By William Bryant III, Clinical Strategies by WB3 When it comes to using AI in clinical research, much of the attention is focused on drug discovery, protocol design, patient recruitment,…...

7+ hour, 12+ min ago   (173+ words) CAR T-cell therapy tested for rheumatoid arthritis to eliminate disease-driving B cells Mid-Day CAR T-cell therapy tested for rheumatoid arthritis to eliminate disease-driving B cells 14 September,2026 08:59 AM IST | Berlin | Agencies Inflammatory foci (magenta) are no longer detectable after the therapy....

7+ hour, 22+ min ago   (117+ words) PharmaDispatch Noxopharm moves lupus skin therapy toward next human trial Noxopharm announced that its lead experimental therapy, SOF-SKN, will advance to an extension clinical study in patients with cutaneous lupus erythematosus, a painful, disfiguring skin condition for which no targeted…...

13+ hour, 41+ min ago   (284+ words) Prepared Foods Superbrewed Food Launches Thryvia Postbiotic Shelf-stable ingredient targets digestive and immune health applications at approximately 200mg per serving Superbrewed Food, Inc., announced the commercial launch of Thryvia, a protein-derived postbiotic that gives brands a new platform for products positioned…...

4+ hour, 28+ min ago   (544+ words) BioSpace Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation The Initiative Will Make Available 100,000 Disease-Specific Whole Genome Sequences Paired with Longitudinal Clinical Outcomes, with a Long-Term Goal of Reaching 1 Million Genomes CHICAGO--(BUSINESS…...

21+ hour, 37+ min ago   (183+ words) Jeddah, September 13, 2026, SPA -- The 11th Scientific Assembly of the Saudi Society of Emergency Medicine (SASEM 2026) is underway in Jeddah under the theme “NextGen EM,” with the participation of a distinguished group of specialists and practitioners in the field to discuss the…...